Odonate Therapeutics, Inc. Insider Trading Activity
Every SEC Form 4 insider transaction reported for Odonate Therapeutics, Inc. (ODT), sourced directly from SEC EDGAR and updated as new filings are accepted.
Quick Answer
Are ODT insiders buying or selling?
Odonate Therapeutics, Inc. insiders reported 40 open-market buys ($138.8M) and 5 sells ($20.3M) across 45 Form 4 filings — a net buying position of $118.5M.
Source: SEC EDGAR Form 4
Key Statistics (as of Dec 10, 2021)
Insider sentiment
Net buyingNet insider flow of $118.5M in net buying.
Recent ODT insider transactions
| Date | Insider | Role | Type | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Dec 10, 2021 | EcoR1 Capital, LLC | 10% Owner | Sale | 5.7M | $1.65 | $9.4M |
| Nov 24, 2021 | Joseph Lewis | 10% Owner | Sale | 400.0K | $1.56 | $623.3K |
| Nov 20, 2021 | Aaron I. Davis | Director, 10% Owner | Sale | 1.2M | $2.08 | $2.5M |
| Nov 20, 2021 | Joseph Lewis | Director, 10% Owner | Sale | 1.0M | $2.06 | $2.1M |
| Nov 19, 2021 | Kevin C Tang | Chief Executive Officer | Sale | 2.7M | $2.09 | $5.7M |
| Dec 31, 2020 | Craig A Johnson | Director | Purchase | 3.0K | $17.00 | $51.0K |
| Dec 30, 2020 | Boxer Capital, LLC | Director, 10% Owner | Purchase | 400.0K | $17.16 | $6.9M |
| Dec 30, 2020 | Aaron I. Davis | Director, 10% Owner | Purchase | 400.0K | $17.16 | $6.9M |
| Dec 23, 2020 | TANG KEVIN C | Chief Executive Officer | Purchase | 275.8K | $15.16 | $4.2M |
| Sep 30, 2020 | Aaron I. Davis | Director, 10% Owner | Purchase | 215.2K | $13.63 | $2.9M |
| Sep 30, 2020 | Boxer Capital, LLC | Director, 10% Owner | Purchase | 215.2K | $13.63 | $2.9M |
| Sep 30, 2020 | TANG KEVIN C | Chief Executive Officer | Purchase | 110.9K | $13.13 | $1.5M |
| Sep 9, 2020 | Aaron I. Davis | Director, 10% Owner | Purchase | 225.0K | $14.98 | $3.4M |
| Sep 9, 2020 | Boxer Capital, LLC | Director, 10% Owner | Purchase | 225.0K | $14.98 | $3.4M |
| Sep 1, 2020 | Boxer Capital, LLC | Director, 10% Owner | Purchase | 1.4M | $14.25 | $20.0M |
| Sep 1, 2020 | Aaron I. Davis | Director, 10% Owner | Purchase | 1.4M | $14.25 | $20.0M |
| Sep 1, 2020 | TANG KEVIN C | Chief Executive Officer | Purchase | 1.1M | $14.25 | $15.0M |
| Jun 28, 2019 | Boxer Capital, LLC | 10% Owner | Purchase | 384.6K | $26.00 | $10.0M |
| Jun 28, 2019 | Jeff L Vacirca | Director | Purchase | 19.2K | $26.00 | $500.0K |
| Jun 28, 2019 | TANG KEVIN C | Chief Executive Officer | Purchase | 769.2K | $26.00 | $20.0M |
| Jun 19, 2019 | TANG KEVIN C | Chief Executive Officer | Purchase | 50.0K | $26.15 | $1.3M |
| Jun 10, 2019 | TANG KEVIN C | Chief Executive Officer | Purchase | 76.3K | $27.36 | $2.1M |
| Jun 5, 2019 | TANG KEVIN C | Chief Executive Officer | Purchase | 93.7K | $24.92 | $2.3M |
| Mar 11, 2019 | TANG KEVIN C | Chief Executive Officer | Purchase | 140.0K | $18.26 | $2.6M |
| Mar 7, 2019 | Jeff L Vacirca | Director | Purchase | 3.0K | $17.00 | $51.0K |
Showing the 25 most recent of 45 Form 4 filings for Odonate Therapeutics, Inc..
Most active ODT insiders
- TANG KEVIN C25 filings
- Boxer Capital, LLC9 filings
- Aaron I. Davis7 filings
- Jeff L Vacirca2 filings
- Craig A Johnson1 filing
Ask anything about ODT insider activity
Use Trabud's AI agent to query Odonate Therapeutics, Inc.'s Form 4 history in plain English — "Show me ODT CEO purchases this year" or compare it against any other ticker.
Open the AI agentODT insider trading FAQ
Are Odonate Therapeutics, Inc. insiders buying or selling?
Across 45 SEC Form 4 filings, Odonate Therapeutics, Inc. (ODT) insiders reported 40 open-market purchases totaling $138.8M and 5 sales totaling $20.3M. That is a net buying position of $118.5M.
How many insiders trade ODT stock?
6 distinct insider filers — officers, directors, 10%+ owners, and investment groups filing jointly — have reported Form 4 transactions for Odonate Therapeutics, Inc.. The most recent filing was accepted on Dec 10, 2021.
Where does Trabud get ODT insider trading data?
All ODT insider trading data comes directly from official SEC EDGAR Form 4 filings, which corporate insiders must submit within two business days of a transaction under Section 16(a) of the Securities Exchange Act of 1934.
Looking for another company? Browse all tracked companies.